“Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 23, no. 1, Feb. 2022, https://doi.org/10.7175/fe.v23i1.1516.